These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30552842)

  • 1. On the (Non-)equivalency of monopolar and bipolar settings for deep brain stimulation fMRI studies of Parkinson's disease patients.
    Hancu I; Boutet A; Fiveland E; Ranjan M; Prusik J; Dimarzio M; Rashid T; Ashe J; Xu D; Kalia SK; Hodaie M; Fasano A; Kucharczyk W; Pilitsis J; Lozano A; Madhavan R
    J Magn Reson Imaging; 2019 Jun; 49(6):1736-1749. PubMed ID: 30552842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Functional MRI to Assess Effects of Deep Brain Stimulation Frequency Changes on Brain Activation in Parkinson Disease.
    DiMarzio M; Madhavan R; Hancu I; Fiveland E; Prusik J; Joel S; Gillogly M; Telkes I; Staudt MD; Durphy J; Shin D; Pilitsis JG
    Neurosurgery; 2021 Jan; 88(2):356-365. PubMed ID: 32985661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting-state functional magnetic resonance imaging of the subthalamic microlesion and stimulation effects in Parkinson's disease: Indications of a principal role of the brainstem.
    Holiga Š; Mueller K; Möller HE; Urgošík D; Růžička E; Schroeter ML; Jech R
    Neuroimage Clin; 2015; 9():264-74. PubMed ID: 26509113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar Directional Deep Brain Stimulation in Essential and Parkinsonian Tremor.
    Steffen JK; Reker P; Mennicken FK; Dembek TA; Dafsari HS; Fink GR; Visser-Vandewalle V; Barbe MT
    Neuromodulation; 2020 Jun; 23(4):543-549. PubMed ID: 32040883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed-loop programming using external responses for deep brain stimulation in Parkinson's disease.
    Sasaki F; Oyama G; Sekimoto S; Nuermaimaiti M; Iwamuro H; Shimo Y; Umemura A; Hattori N
    Parkinsonism Relat Disord; 2021 Mar; 84():47-51. PubMed ID: 33556765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
    van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
    J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI.
    Matias CM; Frizon LA; Nagel SJ; Lobel DA; Machado AG
    J Neurosurg; 2018 Dec; 129(6):1572-1578. PubMed ID: 29372880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLOVER-DBS: Algorithm-Guided Deep Brain Stimulation-Programming Based on External Sensor Feedback Evaluated in a Prospective, Randomized, Crossover, Double-Blind, Two-Center Study.
    Wenzel GR; Roediger J; Brücke C; Marcelino ALA; Gülke E; Pötter-Nerger M; Scholtes H; Wynants K; Juárez Paz LM; Kühn AA
    J Parkinsons Dis; 2021; 11(4):1887-1899. PubMed ID: 34151855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.
    Jiang JL; Chen SY; Hsieh TC; Lee CW; Lin SH; Tsai ST
    J Formos Med Assoc; 2015 Sep; 114(9):835-41. PubMed ID: 24103710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model-Based Deep Brain Stimulation Programming for Parkinson's Disease: The GUIDE Pilot Study.
    Pourfar MH; Mogilner AY; Farris S; Giroux M; Gillego M; Zhao Y; Blum D; Bokil H; Pierre MC
    Stereotact Funct Neurosurg; 2015; 93(4):231-9. PubMed ID: 25998447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.
    Mirzadeh Z; Chapple K; Lambert M; Evidente VG; Mahant P; Ospina MC; Samanta J; Moguel-Cobos G; Salins N; Lieberman A; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2016 Apr; 124(4):902-7. PubMed ID: 26452116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2-relaxometry predicts outcome of DBS in idiopathic Parkinson's disease.
    Lönnfors-Weitzel T; Weitzel T; Slotboom J; Kiefer C; Pollo C; Schüpbach M; Oertel M; Kaelin A; Wiest R
    Neuroimage Clin; 2016; 12():832-837. PubMed ID: 27843765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Tesla MRI of deep brain stimulation patients: safety assessment of coils and pulse sequences.
    Boutet A; Hancu I; Saha U; Crawley A; Xu DS; Ranjan M; Hlasny E; Chen R; Foltz W; Sammartino F; Coblentz A; Kucharczyk W; Lozano AM
    J Neurosurg; 2019 Feb; 132(2):586-594. PubMed ID: 30797197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.
    Achey RL; Yamamoto E; Sexton D; Hammer C; Lee BS; Butler RS; Thompson NR; Nagel SJ; Machado AG; Lobel DA
    J Neurosurg; 2018 Dec; 129(6):1562-1571. PubMed ID: 29473781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebello-striatal interaction mediates effects of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Hanssen H; Steinhardt J; Münchau A; Al-Zubaidi A; Tzvi E; Heldmann M; Schramm P; Neumann A; Rasche D; Saryyeva A; Voges J; Galazky I; Büntjen L; Heinze HJ; Krauss JK; Tronnier V; Münte TF; Brüggemann N
    Parkinsonism Relat Disord; 2019 Oct; 67():99-104. PubMed ID: 31494048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Functional Magnetic Resonance Imaging to Assess How Motor Phenotypes of Parkinson's Disease Respond to Deep Brain Stimulation.
    DiMarzio M; Madhavan R; Joel S; Hancu I; Fiveland E; Prusik J; Gillogly M; Rashid T; MacDonell J; Ashe J; Telkes I; Feustel P; Staudt MD; Shin DS; Durphy J; Hwang R; Hanspal E; Pilitsis JG
    Neuromodulation; 2020 Jun; 23(4):515-524. PubMed ID: 32369255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.